Related Experiment Video
Updated: Jan 26, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
Ad5-EMC6 mediates antitumor activity in gastric cancer cells through the mitochondrial apoptosis pathway
Riyong Li1, Xiaokun Wang2, Xuan Zhang1
1Department of Immunology, Peking University School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, China.
Abstract:
Endoplasmic reticulum membrane protein complex subunit 6 (EMC6), also known as transmembrane protein 93 (transmembrane protein 93, TMEM93), is an autophagy-related protein. EMC6 overexpression inhibits cancer cell growth and induces apoptosis, but the interaction partners of EMC6 and its cellular responsibilities remain incompletely understood. In this study, we report that adenovirus-mediated ectopic overexpression of EMC6 (Ad5-EMC6) in BGC823 and SGC7901 gastric cancer cells decreases the activity of ERK1/2, down-regulates the levels of BCL-2 protein and phosphorylated BCL-2, increases the expression of tBID and BAX, and decreases mitochondrial membrane potential and subsequently leading to cell apoptosis. In a xenograft tumor model, we found that Ad5-EMC6 impairs the tumorigenesis of SGC7901 gastric cancer cells in nude mice. Additionally, Ad5-EMC6 enhances the sensitivity of gastric cancer cells to the chemotherapeutic drug etoposide. Collectively, these results demonstrate that EMC6-induced apoptosis of gastric cancer cells occurs at least partially through the mitochondrial-mediated apoptosis pathway. Our study suggests a rational basis for the potential clinical application of Ad5-EMC6 in gastric cancer.
Insights
Endoplasmic reticulum membrane protein complex subunit 6 (EMC6) overexpression induces apoptosis in gastric cancer cells by activating the mitochondrial pathway. This finding supports EMC6
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Endoplasmic reticulum membrane protein complex subunit 6 (EMC6), also known as transmembrane protein 93 (TMEM93), is an autophagy-related protein.
- The precise cellular functions and interaction partners of EMC6 are not fully elucidated.
- Previous studies indicate EMC6 overexpression can inhibit cancer cell growth and induce apoptosis.
Purpose of the Study:
- To investigate the role of EMC6 in gastric cancer.
- To elucidate the molecular mechanisms underlying EMC6-induced apoptosis in gastric cancer cells.
- To evaluate the therapeutic potential of EMC6 in gastric cancer treatment.
Main Methods:
- Adenovirus-mediated ectopic overexpression of EMC6 (Ad5-EMC6) in BGC823 and SGC7901 gastric cancer cell lines.
- Analysis of apoptosis-related signaling pathways, including ERK1/2, BCL-2, tBID, and BAX.
- Assessment of mitochondrial membrane potential.
- In vivo studies using a xenograft tumor model in nude mice.
- Evaluation of EMC6's effect on sensitivity to etoposide chemotherapy.
Main Results:
- Ad5-EMC6 overexpression decreased ERK1/2 activity and BCL-2 levels while increasing tBID and BAX expression.
- EMC6 induced apoptosis through the mitochondrial pathway, evidenced by decreased mitochondrial membrane potential.
- Ad5-EMC6 impaired gastric cancer cell tumorigenesis in a xenograft model.
- EMC6 enhanced the sensitivity of gastric cancer cells to etoposide.
Conclusions:
- EMC6-induced apoptosis in gastric cancer cells is mediated, at least in part, by the mitochondrial apoptosis pathway.
- EMC6 demonstrates potential as a therapeutic agent for gastric cancer.
- Further clinical investigation of Ad5-EMC6 for gastric cancer treatment is warranted.
Related Concept Videos
Apoptosis
Animal Mitochondrial Genetics
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Gastric Emptying

